Magnetic Resonance Spectroscopy Studies of Glutamate and GABA in Autism: Implications for Excitation-Inhibition Imbalance Theory

Current Developmental Disorders Reports

Volumn 2, Issue 1, 2015, Pages 46-57

  Rojas, Donald C ^a   Becker, Katherine M ^a   Wilson, Lisa B ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

Anterior cingulate gyrus; Autism spectrum disorder; Glx; Neurotransmitter concentration

Indexed keywords

EID: 84964333254     PISSN: None     EISSN: 21962987     Source Type: Journal    
DOI: 10.1007/s40474-014-0032-4     Document Type: Article

References (64)

1. Kogan MD, Blumberg SJ, Schieve LA, Boyle CA, Perrin JM, Ghandour RM, et al. Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007. Pediatrics. 2009;124:1395–403. DOI: 10.1542/peds.2009-1522
2. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators; Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders: autism and developmental disabilities monitoring network, 14 sites, United States, 2008. MMWR Surveill Summ. 2012;61(3):1–19.
3. Butler MG, Youngs EL, Roberts JL, Hellings JA. Assessment and treatment in autism spectrum disorders: a focus on genetics and psychiatry. Autism Res Treat. 2012;2012:242537.
4. Schaefer GB, Lutz RE. Diagnostic yield in the clinical genetic evaluation of autism spectrum disorders. Genet Med. 2006;8:549–56.
5. Ozonoff S, Young GS, Carter A, Messinger D, Yirmiya N, Zwaigenbaum L, et al. Recurrence risk for autism spectrum disorders: a baby Siblings Research Consortium study. Pediatrics. 2011;128:e488–95.
6. Rosenberg RE, Law JK, Yenokyan G, McGready J, Kaufmann WE, Law PA. Characteristics and concordance of autism spectrum disorders among 277 twin pairs. Arch Pediatr Adolesc Med. 2009;163:907–14. DOI: 10.1001/archpediatrics.2009.98
7. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med. 1995;25:63–77. DOI: 10.1017/S0033291700028099
8. Rubenstein JLR, Merzenich MM. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2003;2:255–67. Rubenstein and Merzenich first proposed the glutamate/GABA neurotransmission imbalance as a theoretical account of autism. DOI: 10.1034/j.1601-183X.2003.00037.x
9. Rubenstein JLR. Three hypotheses for developmental defects that may underlie some forms of autism spectrum disorder. Curr Opin Neurol. 2010;23:118–23. DOI: 10.1097/WCO.0b013e328336eb13
10. Harada M, Taki MM, Nose A, Kubo H, Mori K, Nishitani H, et al. Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument. J Autism Dev Disord. 2011;41:447–54. Harada et al. were the first to report reduced GABA concentration in autism using MRS. DOI: 10.1007/s10803-010-1065-0
11. Coghlan S, Horder J, Inkster B, Mendez MA, Murphy DG, Nutt DJ. GABA system dysfunction in autism and related disorders: from synapse to symptoms. Neurosci Biobehav Rev. 2012;36:2044–55. DOI: 10.1016/j.neubiorev.2012.07.005
12. Spence SJ, Schneider MT. The role of epilepsy and epileptiform EEGs in autism spectrum disorders. Pediatr Res. 2009;65:599–606. DOI: 10.1203/PDR.0b013e31819e7168
13. Tuchman R, Alessandri M, Cuccaro M. Autism spectrum disorders and epilepsy: moving towards a comprehensive approach to treatment. Brain Dev. 2010;32:719–30. DOI: 10.1016/j.braindev.2010.05.007
14. Yang Y, Pan C. Role of metabotropic glutamate receptor 7 in autism spectrum disorders: a pilot study. Life Sci. 2013;92:149–53. DOI: 10.1016/j.lfs.2012.11.010
15. Autism Genome Project Consortium, Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet. 2007;39:319–28. DOI: 10.1038/ng1985
16. Buxbaum JD, Silverman JM, Smith CJ, Greenberg DA, Kilifarski M, Reichert J, et al. Association between a GABRB3 polymorphism and autism. Mol Psychiatry. 2002;7:311–6. DOI: 10.1038/sj.mp.4001011
17. Fatemi SH, Reutiman TJ, Folsom TD, Thuras PD. GABA(A) receptor downregulation in brains of subjects with autism. J Autism Dev Disord. 2009;39:223–30. DOI: 10.1007/s10803-008-0646-7
18. Gogolla N, Leblanc JJ, Quast KB, Südhof TC, Fagiolini M, Hensch TK. Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J Neurodevelop Disord. 2009;1:172–81. DOI: 10.1007/s11689-009-9023-x
19. Baudouin SJ. Heterogeneity and convergence: the synaptic pathophysiology of autism. Eur J Neurosci. 2014;39:1107–13. DOI: 10.1111/ejn.12498
20. Purcell AE, Jeon OH, Zimmerman AW, Blue ME, Pevsner J. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology. 2001;57:1618–28. DOI: 10.1212/WNL.57.9.1618
21. Fatemi SH, Folsom TD, Kneeland RE, Liesch SB. Metabotropic glutamate receptor 5 upregulation in children with autism is associated with underexpression of both Fragile X mental retardation protein and GABAA receptor beta 3 in adults with autism. Anat Rec (Hoboken). 2011;294:1635–45. DOI: 10.1002/ar.21299
22. Oblak AL, Gibbs TT, Blatt GJ. Decreased GABA(B) receptors in the cingulate cortex and fusiform gyrus in autism. J Neurochem. 2010;114:1414–23.
23. Oblak AL, Gibbs TT, Blatt GJ. Reduced GABAA receptors and benzodiazepine binding sites in the posterior cingulate cortex and fusiform gyrus in autism. Brain Res. 2011;1380:218–28. DOI: 10.1016/j.brainres.2010.09.021
24. Blatt GJ, Fatemi SH. Alterations in GABAergic biomarkers in the autism brain: research findings and clinical implications. Anat Rec (Hoboken). 2011;294:1646–52. DOI: 10.1002/ar.21252
25. Yip J, Soghomonian J-J, Blatt GJ. Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications. Acta Neuropathol. 2007;113:559–68. DOI: 10.1007/s00401-006-0176-3
26. Shimmura C, Suzuki K, Iwata Y, Tsuchiya KJ, Ohno K, Matsuzaki H, et al. Enzymes in the glutamate-glutamine cycle in the anterior cingulate cortex in postmortem brain of subjects with autism. Mol Autism. 2013;4:6. DOI: 10.1186/2040-2392-4-6
27. van der Graaf M. In vivo magnetic resonance spectroscopy: basic methodology and clinical applications. Eur Biophys J. 2010;39:527–40. DOI: 10.1007/s00249-009-0517-y
28. Baruth JM, Wall CA, Patterson MC, Port JD. Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review. Autism Res. 2013;6:119–33. DOI: 10.1002/aur.1273
29. 1 H-MRS studies of various metabolites in autism. The study reports a strong age-association for NAA findings in autism, but does not formally analyze Glx or Glu due to the small number of studies reporting these variables. DOI: 10.1038/tp.2011.65
30. Puts NAJ, Edden RAE. In vivo magnetic resonance spectroscopy of GABA: a methodological review. Prog Nucl Magn Reson Spectrosc. 2012;60:29–41. DOI: 10.1016/j.pnmrs.2011.06.001
31. Hassan TH, Abdelrahman HM, Fattah NRA, El-Masry NM, Hashim HM, El-Gerby KM, et al. Blood and brain glutamate levels in children with autistic disorder. Res Autism Spectr Disord. 2013;7:541–8. This is the only MRS study of amino acid neurotransmitters in autism to include both MRS quantification and blood levels of glutamate. The correlation between blood and MRS levels was significant. DOI: 10.1016/j.rasd.2012.12.005
32. Doyle-Thomas KAR, Card D, Soorya LV, Wang AT, Fan J, Anagnostou E. Metabolic mapping of deep brain structures and associations with symptomatology in autism spectrum disorders. Res Autism Spectr Disord. 2014;8:44–51. DOI: 10.1016/j.rasd.2013.10.003
33. Horder J, Wilson CE, Mendez MA, Murphy DG. Autistic traits and abnormal sensory experiences in adults. J Autism Dev Disord. 2013;44:1461–9. DOI: 10.1007/s10803-013-2012-7
34. Page LA, Daly E, Schmitz N, Simmons A, Toal F, Deeley Q, et al. In vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism. Am J Psychiatry. 2006;163:2189–92.
35. Joshi G, Biederman J, Wozniak J, Goldin RL, Crowley D, Furtak S, et al. Magnetic resonance spectroscopy study of the glutamatergic system in adolescent males with high-functioning autistic disorder: a pilot study at 4T. Eur Arch Psychiatry Clin Neurosci. 2013;263:379–84. DOI: 10.1007/s00406-012-0369-9
36. Hardan AY, Minshew NJ, Melhem NM, Srihari S, Jo B, Bansal R, et al. An MRI and proton spectroscopy study of the thalamus in children with autism. Psychiatry Res. 2008;163:97–105. DOI: 10.1016/j.pscychresns.2007.12.002
37. Bernardi S, Anagnostou E, Shen J, Kolevzon A, Buxbaum JD, Hollander E, et al. In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism. Brain Res. 2011;1380:198–205. DOI: 10.1016/j.brainres.2010.12.057
38. van Elst LT, Maier S, Fangmeier T, Endres D, Mueller GT, Nickel K, et al. Disturbed cingulate glutamate metabolism in adults with high-functioning autism spectrum disorder: evidence in support of the excitatory/inhibitory imbalance hypothesis. Mol Psychiatry. 2014;19:1314–25. DOI: 10.1038/mp.2014.62
39. DeVito TJ, Drost DJ, Neufeld RWJ, Rajakumar N, Pavlosky W, Williamson P, et al. Evidence for cortical dysfunction in autism: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry. 2007;61:465–73. DOI: 10.1016/j.biopsych.2006.07.022
40. 1H]MRS study. Transl Psychiatry. 2013;3:e279. DOI: 10.1038/tp.2013.53
41. Bejjani A, O’Neill J, Kim JA, Frew AJ, Yee VW, Ly R, et al. Elevated glutamatergic compounds in pregenual anterior cingulate in pediatric autism spectrum disorder demonstrated by 1H MRS and 1H MRSI. PLoS One. 2012;7:e38786. DOI: 10.1371/journal.pone.0038786
42. Brown MS, Singel D, Hepburn S, Rojas DC. Increased glutamate concentration in the auditory cortex of persons with autism and first-degree relatives: a 1H-MRS study. Autism Res. 2013;6:1–10. DOI: 10.1002/aur.1260
43. Corrigan NM, Shaw DWW, Estes AM, Richards TL, Munson J, Friedman SD, et al. Atypical developmental patterns of brain chemistry in children with autism spectrum disorder. JAMA Psychiatry. 2013;70:964–74. To date, the Corrigan et al. study is the largest MRS study published in autism and is also the only one to employ a longitudinal design. DOI: 10.1001/jamapsychiatry.2013.1388
44. 1 H-MRS. DOI: 10.1016/j.neuroimage.2013.05.068
45. 1 H-MRS measured reductions in GABA in both children with autism and siblings of individuals with autism. This suggests the possible heritability of the finding in autism. DOI: 10.1016/j.neuroimage.2013.01.045
46. Sanacora G, Mason GF, Rothman DL, Krystal JH. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry. 2002;159:663–5. DOI: 10.1176/appi.ajp.159.4.663
47. Bhagwagar Z, Wylezinska M, Taylor M, Jezzard P, Matthews PM, Cowen PJ. Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am J Psychiatry. 2004;161:368–70. DOI: 10.1176/appi.ajp.161.2.368
48. Rojas DC. The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment. J Neural Transm. 2014;121:891–905. DOI: 10.1007/s00702-014-1216-0
49. Ghanizadeh A. Increased glutamate and homocysteine and decreased glutamine levels in autism: a review and strategies for future studies of amino acids in autism. Dis Markers. 2013;35:281–6. DOI: 10.1155/2013/536521
50. Moreno-Fuenmayor H, Borjas L, Arrieta A, Valera V, Socorro-Candanoza L. Plasma excitatory amino acids in autism. Investig Clin. 1996;37:113–28.
51. Shinohe A, Hashimoto K, Nakamura K, Tsujii M, Iwata Y, Tsuchiya KJ, et al. Increased serum levels of glutamate in adult patients with autism. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:1472–7. DOI: 10.1016/j.pnpbp.2006.06.013
52. Shimmura C, Suda S, Tsuchiya KJ, Hashimoto K, Ohno K, Matsuzaki H, et al. Alteration of plasma glutamate and glutamine levels in children with high-functioning autism. PLoS One. 2011;6:e25340. DOI: 10.1371/journal.pone.0025340
53. Tirouvanziam R, Obukhanych TV, Laval J, Aronov PA, Libove R, Banerjee AG, et al. Distinct plasma profile of polar neutral amino acids, leucine, and glutamate in children with autism spectrum disorders. J Autism Dev Disord. 2011;42:827–36. DOI: 10.1007/s10803-011-1314-x
54. Rolf LH, Haarmann FY, Grotemeyer KH, Kehrer H. Serotonin and amino acid content in platelets of autistic children. Acta Psychiatr Scand. 1993;87:312–6. DOI: 10.1111/j.1600-0447.1993.tb03378.x
55. Dhossche DD, Applegate HH, Martinez JJ. 7. Elevated plasma gamma-aminobutyric acid (GABA) levels in autistic youngsters: stimulus for a GABA hypothesis of autism. Med Sci Monit. 2002;8:PR1–6.
56. Kaiser LG, Schuff N, Cashdollar N, Weiner MW. Age-related glutamate and glutamine concentration changes in normal human brain: 1H MR spectroscopy study at 4T. Neurobiol Aging. 2005;26:665–72. DOI: 10.1016/j.neurobiolaging.2004.07.001
57. Sailasuta N, Ernst T, Chang L. Regional variations and the effects of age and gender on glutamate concentrations in the human brain. Magn Reson Imaging. 2008;26:667–75. DOI: 10.1016/j.mri.2007.06.007
58. Phan KL, Fitzgerald DA, Cortese BM, Seraji-Bozorgzad N, Tancer ME, Moore GJ. Anterior cingulate neurochemistry in social anxiety disorder: 1H-MRS at 4 Tesla. Neuroreport. 2005;16:183–6. DOI: 10.1097/00001756-200502080-00024
59. Doelken MT, Mennecke A, Stadlbauer A, Kecskeméti L, Kasper BS, Struffert T, et al. Multi-voxel magnetic resonance spectroscopy at 3T in patients with idiopathic generalised epilepsy. Seizure. 2010;19:485–92. DOI: 10.1016/j.seizure.2010.07.005
60. Whiteside SP, Port JD, Deacon BJ, Abramowitz JS. A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety. Psychiatry Res. 2006;146:137–47. DOI: 10.1016/j.pscychresns.2005.12.006
61. Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 2007;64:193–200. DOI: 10.1001/archpsyc.64.2.193
62. Edden RAE, Crocetti D, Zhu H, Gilbert DL, Mostofsky SH. Reduced GABA concentration in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2012;69:750–3. DOI: 10.1001/archgenpsychiatry.2011.2280
63. Bhagwagar Z, Wylezinska M, Jezzard P, Evans J, Boorman E, M Matthews P, et al. Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients. Int J Neuropsychopharmacol. 2008;11:255–60. DOI: 10.1017/S1461145707007924
64. Myers JFM, Evans CJ, Kalk NJ, Edden RAE, Lingford-Hughes AR. Measurement of GABA using J-difference edited 1H-MRS following modulation of synaptic GABA concentration with tiagabine. Synapse. 2014;68:355–62. DOI: 10.1002/syn.21747